# HIVR4P 2023, the 5th HIV Research for Prevention Conference, Lima, Peru, and virtually, 22-26 October 2023

> **NIH NIH R13** · IAS · 2023 · $1,400,000

## Abstract

Project Summary
UNAIDS set ambitious prevention goals and targets for HIV incidence reductions for 2020. We were not on a
trajectory for success for those goals before the COVID-19 pandemic, and are at risk of further expansion of HIV
epidemics. Declines in surveillance capacity also threaten our ability to assess HIV epidemic trajectories in many
settings of risk. We face daunting challenges of ongoing transmission, and of growing gaps and disparities in
primary prevention. Yet the existing and expanding toolkit for biomedical prevention of HIV infection has never
had as much diversity, and as many high efficacy options, as today. Adolescents and younger adults in African
settings and in key populations globally continue to bear the greatest burdens of HIV incidence, and to have the
greatest challenges using and benefitting from biomedical HIV prevention advances. This population will be at
the center of HIVR4P 2023. A particular focus will also be made on people who inject drugs or who use
substances in sexual settings and have been understudied and underserved in HIV prevention. In the field of
HIV vaccines, the COVID-19 pandemic highlighted new threats in terms of vaccines hesitancy. It is time now to
investigate and report on new ways to addressing hesitancy and to understanding barriers to the uptake of novel
HIV vaccines, prevention technologies and approaches.
HIVR4P 2023, the 5th HIV Research for Prevention Conference taking place from 22 to 26 October 2023 in
Lima, Peru, will be an opportunity for the HIV prevention community to hear, debate and weigh new scientific
evidence, and to assess the increasingly complex prevention landscape and the next generation of research
questions, including those for HIV vaccines, and the interactions of vaccines with non-vaccine prevention
modalities. Lima was chosen as the host city to highlight scientific excellence in prevention research in the Latin
American region while also drawing attention to the spiraling vulnerabilities and epidemics in the region.
To facilitate everyone’s access to the conference regardless of their ability or willingness to travel, and
recognizing that potential obstacles - including access to COVID-19 vaccines - might prevent key stakeholders
particularly from countries with a high burden of HIV from travelling internationally, HIVR4P 2023 will be a fully
hybrid conference. It will connect the two audiences both in Lima, which will provide a compelling venue for
HIVR4P 2023 as a leading center of HIV prevention science, and online via the virtual conference platform.
Specific aims for HIVR4P 2023 are to:
1. Convene the world’s experts in HIV prevention and related fields to advance scientific knowledge,
 present new research findings, and enhance global scientific and community collaborations
2. Advance HIV prevention technologies and implementation approaches that are tailored to the needs of
 those most at risk including adolescents and young adults, men who have sex wit...

## Key facts

- **NIH application ID:** 10617933
- **Project number:** 1R13AI174893-01
- **Recipient organization:** IAS
- **Principal Investigator:** Christopher C. Beyrer
- **Activity code:** R13 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2023
- **Award amount:** $1,400,000
- **Award type:** 1
- **Project period:** 2023-03-01 → 2025-02-28

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10617933

## Citation

> US National Institutes of Health, RePORTER application 10617933, HIVR4P 2023, the 5th HIV Research for Prevention Conference, Lima, Peru, and virtually, 22-26 October 2023 (1R13AI174893-01). Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/grant/nih/10617933. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*